Neudata Neudata - Alternative Data Intelligence
Email [email protected]
  • For data buyers
    • Investment Managers
    • Private Equity & Venture Capital
    • Corporate
  • For data providers
    • Neudata Provider Premium
  • Events
  • About
    • People
    • Careers
    • Press Resources
    • Contact
  • News
  • Sign in
Request a trial

Alternative Data News and Insight

  • All
  • News
  • Signal
  • Intelligence
  • Literature Review
  • Sentry
  • Tidbits
  • Sentry Report
  • Events
  • Measuring the invisible – alternative sources of environmental performance data

    Historically, environmental performance data has heavily relied upon disclosure information, which companies are not always obligated to report on. However, recent technological developments have enabled us to measure environmental performance in more advanced ways. These datasets can 1) attribute point sources of invisible greenhouse gas emissions via remote satellite technology, and 2) quantify ESG-related intellectual capital through patent filing analysis.
    Intelligence 23 Oct 2019
  • Trademark activity as a leading economic indicator

    In 2018, we published a piece discussing the potential correlations between trademark registration volume and firm financial performance. But what about the macroeconomic use case? One year later, we investigate whether trademark filing volume can provide an aggregate indicator of business cycle shifts.
    Intelligence 17 Oct 2019
  • Generating Alpha from Pharmaceutical Events using ML & NLP

    The stock market reaction to a single pharmaceutical event, such as a drug approval, repositioning, or adverse event, can have a spillover effect. Beyond the effect on the associated company’s stock price, an event may trigger a latent movement in the stock price of other publicly traded pharmaceutical companies. Research suggests that these sympathetic price movements may be a result of common attributes shared by the companies (beyond economic fundamentals), which are embedded in human language. In this piece, we explore how investors could leverage NLP to detect these ‘hidden relationships’ and generate alpha from pharmaceutical stocks.
    Intelligence 9 Oct 2019
  • Forecasting crop prices using alt data

    In this Intelligence report, we summarise a few alternative datasets that soft commodity investors can leverage in order to predict the prices of crops. Specifically, the report discusses datasets that can offer investors 1) a leading advantage, and/or 2) more visibility into previously opaque regions.
    Intelligence 2 Oct 2019
  • September Tidbits: Hodie Mihi, Cras Tibi

    In this Neudata tidbit’s edition, we share some thoughts on the headline stories of the past four weeks, as well as a couple of under-the-radar developments in consumer transactional data and ESG.
    Tidbits 30 Sep 2019
  • ESG 3.0 – a multilateral alternative data model

    Just because a company says its business practices are ethical, doesn’t necessarily mean they actually are. Recent studies suggest that companies are able to influence their ESG score by greenwashing corporate sustainability information. In this report, we argue that alternative data can be used to test ethical claims as well as build a more accurate and objective ESG risk signal.
    Intelligence 24 Sep 2019
  • Open Banking and Alternative Data

    September 14th was an important milestone in the march towards Open Banking. It marked the original deadline for implementation of PSD2 or ‘the second Payment Services Directive.’ If you don’t know what that is, and you are currently purchasing (or thinking of purchasing) European consumer transactional data – you may want to read on. In this report, we introduce the ubiquitous, yet often poorly understood, FinTech phenomenon of Open Banking, and consider the implications of these regulations on both buyers and sellers of alternative data.
    Intelligence 19 Sep 2019
  • Alternative Data for Healthcare Investors (Part IV): Claims vs EHRs

    In the following Intelligence piece, we explore healthcare claims and electronic health records (EHRs) as alternative data sources for investors. Healthcare claims and EHRs can offer valuable insights into drug/medical device prescribing and utilisation trends. This information has clear applications for investors in pharmaceutical, biotech, and medical device/equipment companies as well as companies responsible for paying healthcare claims such as managed care organisations or other health insurers.
    Intelligence 12 Sep 2019
  • Exposing Accounting Scandals In China Using Alt Data

    Accounting scandals can lead to crippling losses for the uninformed investor - from the Enron and Worldcom scandals to the more recent fraudulent activity of Kangde Xin and Kangmei in China. This article considers the ever-increasing influence of Chinese capital markets, company-level risk factors for financial misreporting, as well as how investors can use alternative data sources to detect early signs of malfeasance by China-listed companies.
    Intelligence 4 Sep 2019
  • August Tidbits: Apocalypse When?

    Highlights of this month’s tidbits include a debrief on the purported e-receipt apocalypse, a chance meeting between a data scraper and its data source, as well as some positive news from the land of TV tracking datasets.
    Tidbits 30 Aug 2019
1 … 55 56 57 58 59 60 61 62 63 … 69

Sign up for Alternative data news and trends

Find out more about Neudata and keep up-to-date by signing up to our email newsletter.

Follow us

Neudata Ltd © 2022. All rights reserved.
  • Terms and Conditions
  • Privacy Statement
  • Cookies